Book contents
- Common Pitfalls in Cognitive and Behavioral Neurology
- Common Pitfalls in Cognitive and Behavioral Neurology
- Copyright page
- Dedication
- Contents
- Diseases Discussed in the Book
- Preface
- Acknowledgements
- Abbreviations
- Part 1 Missing the Diagnosis Altogether
- Part 2 Misidentifying the Impaired Cognitive Domain
- Part 3 Missing Important Clues in the History
- Part 4 Failure of Pattern Recognition
- Part 5 Difficult-to-Characterize Cognitive/Behavioral Disorders
- Part 6 Clinical Findings That Are Subtle
- Part 7 Misinterpreting Test Results
- Part 8 Attributing Findings to a Known or Suspected Disorder
- Case 36 “I Have Snored All My Life and It Never Affected My Work”
- Case 37 Starting Early
- Case 38 “I Have Been Taking the Same Medications for Years”
- Case 39 Cognitive Impairment and Blood Pressure Fluctuations
- Case 40 Corticobasal: The Syndrome versus the Pathology
- Part 9 Missing Radiographic Clues
- Part 10 Management Misadventures
- Index
- Plate Section (PDF Only)
- References
Case 38 - “I Have Been Taking the Same Medications for Years”
from Part 8 - Attributing Findings to a Known or Suspected Disorder
Published online by Cambridge University Press: 03 November 2020
Book contents
- Common Pitfalls in Cognitive and Behavioral Neurology
- Common Pitfalls in Cognitive and Behavioral Neurology
- Copyright page
- Dedication
- Contents
- Diseases Discussed in the Book
- Preface
- Acknowledgements
- Abbreviations
- Part 1 Missing the Diagnosis Altogether
- Part 2 Misidentifying the Impaired Cognitive Domain
- Part 3 Missing Important Clues in the History
- Part 4 Failure of Pattern Recognition
- Part 5 Difficult-to-Characterize Cognitive/Behavioral Disorders
- Part 6 Clinical Findings That Are Subtle
- Part 7 Misinterpreting Test Results
- Part 8 Attributing Findings to a Known or Suspected Disorder
- Case 36 “I Have Snored All My Life and It Never Affected My Work”
- Case 37 Starting Early
- Case 38 “I Have Been Taking the Same Medications for Years”
- Case 39 Cognitive Impairment and Blood Pressure Fluctuations
- Case 40 Corticobasal: The Syndrome versus the Pathology
- Part 9 Missing Radiographic Clues
- Part 10 Management Misadventures
- Index
- Plate Section (PDF Only)
- References
Summary
This 67-year-old right-handed woman presented with a 2-year history of tremor and gait difficulties followed by cognitive impairment. The rest tremor appeared two years before her initial exam, followed six months later by falls and slow gait. Over the last year, she noticed difficulty maintaining her focus and frequently lost her train of thought. Word-finding impairment with frequent word substitutions emerged in addition to difficulties operating household appliances (e.g., remote control), which were not attributed to motor deficits. Her sister noticed she was forgetful and repetitive. She had experienced depression since age 17, currently managed with paroxetine 50 mg and amitriptyline 200 mg daily. In addition, she was on diazepam 10 mg daily for anxiety and zolpidem 10 mg at bedtime as a sleeping aid. On exam, she exhibited asymmetric resting tremor, bradykinesia, and rigidity. Her gait was slow with decreased stride length and impaired postural reflexes.
- Type
- Chapter
- Information
- Common Pitfalls in Cognitive and Behavioral NeurologyA Case-Based Approach, pp. 119 - 121Publisher: Cambridge University PressPrint publication year: 2020
References
Billioti de Gage, S. et al. 2014. Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ 349 g5205.CrossRefGoogle ScholarPubMed
Buffett-Jerrott, S. E. and Stewart, S. H. 2002. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 8(1) 45–58.CrossRefGoogle ScholarPubMed
Cao, Y. J. et al. 2008. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 83(3) 422–429.CrossRefGoogle ScholarPubMed
Carriere, I. et al. 2009. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 169(14) 1317–1324.CrossRefGoogle Scholar
Gray, S. L. et al. 2015. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175(3) 401–407.CrossRefGoogle ScholarPubMed
Hilmer, S. N. et al. 2009. Drug burden index score and functional decline in older people. Am J Med 122(12) 1142–1149.CrossRefGoogle ScholarPubMed
Kaufman, D. W. et al. 2002. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287(3) 337–344.CrossRefGoogle ScholarPubMed
Lechevallier-Michel, N. et al. 2005. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 59(2) 143–151.CrossRefGoogle ScholarPubMed
Mulsant, B. H. et al. 2003. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60(2) 198–203.CrossRefGoogle Scholar
Nebes, R. D. et al. 2005. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology 65(9) 1487–1489.CrossRefGoogle ScholarPubMed
Papenberg, G. et al. 2017. Anticholinergic drug use is associated with episodic memory decline in older adults without dementia. Neurobiol Aging 55 27–32.CrossRefGoogle ScholarPubMed
Risacher, S. L. et al. 2016. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol 73(6) 721–732.Google Scholar
Villalba-Moreno, A. M. et al. 2016. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr 62 1–8.CrossRefGoogle ScholarPubMed